| Dataset | DrugBank Drug Targets |
| Category | physical interactions |
| Type | drug |
| Description | A diastereoisomeric mixture composed of approximately equal amounts of a double racemate of four of the sixteen possible diastereoisomers of methyl (13E)-11,16-dihydroxy-16-methyl-9-oxoprost-13-en-1-oate that is racemic prostaglandin E1 which is lacking the hydroxy group at position 15, but which has an additional hydroxy group at position 16. It is a synthetic prostaglandin E1 analogue, used in the treatment of gastric and duodenal ulcers. A weak abortifacient, it is also used for cervical ripening prior to surgical termination of pregnancy. The (11R,16S)-diastereoisomer is the pharmacologically active form. (Chemical Entities of Biological Interest Ontology, CHEBI_63610) |
| External Link | http://www.drugbank.ca/drugs/DB00929 |
| Similar Terms | |
| Downloads & Tools |
3 interacting proteins for the Misoprostol drug from the curated DrugBank Drug Targets dataset.
